BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11242322)

  • 1. Linkage to medical services in the Drug Abuse Treatment Outcome Study.
    Friedmann PD; Lemon SC; Stein MD; Etheridge RM; D'Aunno TA
    Med Care; 2001 Mar; 39(3):284-95. PubMed ID: 11242322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical and psychosocial services in drug abuse treatment: do stronger linkages promote client utilization?
    Friedmann PD; D'Aunno TA; Jin L; Alexander JA
    Health Serv Res; 2000 Jun; 35(2):443-65. PubMed ID: 10857471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of primary medical care on addiction and medical severity in substance abuse treatment programs.
    Friedmann PD; Zhang Z; Hendrickson J; Stein MD; Gerstein DR
    J Gen Intern Med; 2003 Jan; 18(1):1-8. PubMed ID: 12534757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug treatment, health, and social service utilization by substance abusing women from a community-based sample.
    Hansen H; Alegría M; Cabán CA; Peña M; Lai S; Shrout P
    Med Care; 2004 Nov; 42(11):1117-24. PubMed ID: 15586839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do mechanisms that link addiction treatment patients to primary care influence subsequent utilization of emergency and hospital care?
    Friedmann PD; Hendrickson JC; Gerstein DR; Zhang Z; Stein MD
    Med Care; 2006 Jan; 44(1):8-15. PubMed ID: 16365607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of the Effects of an Intervention Aiming to Link Patients Receiving Addiction Treatment With Health Care: The LINKAGE Clinical Trial.
    Weisner CM; Chi FW; Lu Y; Ross TB; Wood SB; Hinman A; Pating D; Satre D; Sterling SA
    JAMA Psychiatry; 2016 Aug; 73(8):804-14. PubMed ID: 27332703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment for substance abuse in Australia: a comparison of public and private programs.
    McNeese-Smith DK
    Int J Psychiatr Nurs Res; 2003 Sep; 9(1):1025-38. PubMed ID: 14533233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transportation and retention in outpatient drug abuse treatment programs.
    Friedmann PD; Lemon SC; Stein MD
    J Subst Abuse Treat; 2001 Sep; 21(2):97-103. PubMed ID: 11551738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Special Services for Women in Substance Use Disorders Treatment: How Does the Department of Veterans Affairs Compare with Other Providers?
    Heslin KC; Gable A; Dobalian A
    Womens Health Issues; 2015; 25(6):666-72. PubMed ID: 26329259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient drug treatment program directors' hepatitis C-related beliefs and their relationship to the provision of HCV services.
    Astone JM; Strauss SM; Hagan H; Des Jarlais DC
    Am J Drug Alcohol Abuse; 2004 Nov; 30(4):783-97. PubMed ID: 15624549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital-based alcohol and drug specialty consultation service: does it work?
    Fleming MF; Wilk A; Kruger J; Kropp S; Manwell L; Desnoyers P
    South Med J; 1995 Mar; 88(3):275-82. PubMed ID: 7886522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The financial challenges of obtaining quality substance abuse treatment.
    Harkreader M
    Tenn Nurse; 2009; 72(2):13. PubMed ID: 19588708
    [No Abstract]   [Full Text] [Related]  

  • 14. Organizational correlates of service availability in outpatient substance abuse treatment programs.
    Edwards JR; Knight DK; Flynn PM
    J Behav Health Serv Res; 2011 Oct; 38(4):432-43. PubMed ID: 21107915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of mental health and substance abuse treatment services among adults with HIV in the United States.
    Burnam MA; Bing EG; Morton SC; Sherbourne C; Fleishman JA; London AS; Vitiello B; Stein M; Bozzette SA; Shapiro MF
    Arch Gen Psychiatry; 2001 Aug; 58(8):729-36. PubMed ID: 11483138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outreach developmental services to children of patients in treatment for substance abuse.
    Shulman LH; Shapira SR; Hirshfield S
    Am J Public Health; 2000 Dec; 90(12):1930-3. PubMed ID: 11111270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization and costs of substance abuse services within The HMO Group.
    Levin BL
    HMO Pract; 1993 Mar; 7(1):28-34. PubMed ID: 10171407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Project ASSERT: an ED-based intervention to increase access to primary care, preventive services, and the substance abuse treatment system.
    Bernstein E; Bernstein J; Levenson S
    Ann Emerg Med; 1997 Aug; 30(2):181-9. PubMed ID: 9250643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient treatment entry and health care utilization after a combined medical/substance abuse intervention for hospitalized medical patients.
    O'Toole TP; Strain EC; Wand G; McCaul ME; Barnhart M
    J Gen Intern Med; 2002 May; 17(5):334-40. PubMed ID: 12047729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017.
    Parcesepe AM; Lancaster K; Edelman EJ; DeBoni R; Ross J; Atwoli L; Tlali M; Althoff K; Tine J; Duda SN; Wester CW; Nash D;
    PLoS One; 2020; 15(8):e0237772. PubMed ID: 32853246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.